Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP comment request

This article was originally published in The Tan Sheet

Executive Summary

The United States Pharmacopeia seeks comment on proposed revisions to the General Notices and Requirements in "The United States Pharmacopeia," "USP - National Formulary" and the General Provisions and Requirements in the "Food Chemicals Codex," the standards-setting authority says May 21. "Since the General Notices are often difficult to navigate, the purpose of the proposed update is to increase overall clarity," the organization explains. With this goal, USP's 1draft aims to update the language, "some of which dates back to at least 1920," as well as clarify several points including the distinction between "official" and "authorized" text, USP says...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel